Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ALIM

Alimera Sciences (ALIM) Stock Price, News & Analysis

Alimera Sciences logo

About Alimera Sciences Stock (NASDAQ:ALIM)

Advanced Chart

Key Stats

Today's Range
$5.54
$5.54
50-Day Range
$5.19
$5.60
52-Week Range
$2.61
$5.65
Volume
N/A
Average Volume
376,318 shs
Market Capitalization
$290.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ALIM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alimera Sciences and its competitors with MarketBeat's FREE daily newsletter.

ALIM Stock News Headlines

Alimera Sciences Inc.
ANI Pharmaceuticals’ Record Growth and Strategic Acquisition
Trump Makes Major Crypto Announcement
Pay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift all boats equally. They're wrong. One project stands to benefit more than any other – not by accident, but seemingly by design.
Alimera Sciences, Inc. (NASDAQ:ALIM): When Will It Breakeven?
Alimera Sciences, Inc. (ALIM)
See More Headlines

ALIM Stock Analysis - Frequently Asked Questions

Alimera Sciences, Inc. (NASDAQ:ALIM) released its quarterly earnings results on Tuesday, August, 6th. The biopharmaceutical company reported ($0.06) EPS for the quarter, missing analysts' consensus estimates of ($0.04) by $0.02. The biopharmaceutical company had revenue of $27 million for the quarter, compared to analysts' expectations of $25.76 million. Alimera Sciences had a negative trailing twelve-month return on equity of 33.70% and a negative net margin of 14.74%.

Alimera Sciences shares reverse split before market open on Friday, November 15th 2019.The 1-15 reverse split was announced on Thursday, November 7th 2019. The number of shares owned by shareholders was adjusted after the market closes on Thursday, November 14th 2019. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Alimera Sciences investors own include Advanced Micro Devices (AMD), Tesla (TSLA), Meta Platforms (META), Netflix (NFLX), NVIDIA (NVDA), JPMorgan Chase & Co. (JPM) and Alphabet (GOOG).

Company Calendar

Last Earnings
8/06/2024
Today
7/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ALIM
Employees
150
Year Founded
2003

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$20.13 million
Pretax Margin
-14.76%

Debt

Sales & Book Value

Annual Sales
$99.68 million
Price / Cash Flow
N/A
Book Value
$0.88 per share
Price / Book
6.30

Miscellaneous

Free Float
35,939,000
Market Cap
$290.24 million
Optionable
Optionable
Beta
1.25

Social Links

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:ALIM) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners